vinblastine sulfate

vinblastine sulfate structural formula

structural formula

business number 03w8
molecular formula c46h60n4o13s
molecular weight 909.05
label

vincaleukoblastine sulfate salt

numbering system

cas number:143-67-9

mdl number:mfcd00082457

einecs number:205-606-0

rtecs number:yy8400000

brn number:3659812

pubchem number:24278771

physical property data

1. physical property data:

1. melting point (ºc): 267ºc

2. specific optical rotation (º): -21.7 º

toxicological data

2. �physics data:

1, acute toxicity: rat oral ld50: 305 mg/kg;

rat abdominal cavity ld50: 1 mg/kg;

rat subcutaneous ld50: 355 mg/kg;

rat veinld5037 mg/kg;

mice orallyld50: 423 mg/kg;

mouse abdominal cavity ld50: 2700 ug/kg

mouse subcutaneous ld50: 324 mg/kg.

ecological data

3. ecological data:

other harmful effect: this substance may be harmful to the environment, and special attention should be paid to water bodies.

molecular structure data

none

compute chemical data

4. calculated chemical data:

1. hydrogen bonding number of donors: 5

2. hydrogen bonding number of receptors: 16

3. rotatable number of chemical bonds: 10

4. topological molecules polar surface area (tpsa):229

5. heavy atoms quantity: 64

6. surface charge :0

7. complexity :1780

8. isotope atomic number:0

9. determine the number of atomic stereocenters:9

10. uncertain number of atomic stereocenters:0

11. determine the number of stereocenters of chemical bonds:0

12. uncertain number of chemical bond stereocenters:0

13. number of covalent bond units: 2

properties and stability

stable under normal temperature and pressure.

storage method

save at 2-8ºc.

synthesis method

none

purpose

1.anti-tumor drugs, used to treat hodgkin’s disease and chorioepithelial carcinoma, and also have certain effects on lymphosarcoma, acute leukemia, breast cancer, etc..

2.anti-tumor drug for malignant lymphoma

an’; mso-bidi-font-family: 宋体”>

1.anti-tumor drugs, used to treat hodgkin’s disease and chorioepithelial carcinoma, and also have certain effects on lymphosarcoma, acute leukemia, breast cancer, etc..

2.anti-tumor drug for malignant lymphoma

This article is from the Internet, does not represent the position of Toluene diisocyanate reproduced please specify the source.https://www.chemicalchem.com/archives/27663

author:

Previous article
Next article
Contact Us

Contact us

+86 - 152 2121 6908

Online consultation: QQ交谈

E-mail: sales@newtopchem.com

Working hours: Monday to Friday, 9:00-17:30, closed on holidays
Follow wechat
Scan wechat and follow us

Scan wechat and follow us

Follow Weibo
Back to top
Home
E-mail
Products
Search